Expanding the scope of screening for pancreatic exocrine insufficiency beyond traditional at-risk groups

Abstract

Get full access to this article

View all access options for this article.

References

Edwards

Krishnan

Jalal

A case report of pancreatic exocrine insufficiency in a patient with Parkinson’s disease: a coincidence or is there more to it than meets the eye?

J R Coll Physicians Edinb. Epub ahead of print 23 February 2024. DOI: 10.1177/14782715241234078.

Lewis

An updated review of exocrine pancreatic insufficiency prevalence finds EPI to be more common in general population than rates of co-conditions. J Gastrointest Liver Dis. Epub ahead of print 22 February 2024. DOI: 10.15403/jgld-5005.

Rothenbacher

Löw

Hardt

, et al. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study. Scand J Gastroenterol 2005; 40(6): 697–704. DOI: 10.1080/00365520510023116.

Herzig

K-H

Purhonen

A-K

Räsänen

, et al. Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus. BMC Geriatr 2011; 11: 4.

Mathew

Fernandes

Andreyev

HJN

. What is the significance of a faecal elastase-1 level between 200 and 500μg/g? Frontline Gastroenterol 2023; 14: 371–376.

Campbell

Francis

Kurien

, et al. PWE-208 How common is pancreatic exocrine insufficiency in primary care? Gut 2015; 64: A303.